Tampere University Hospital

At Tampere University Hospital, a large share of clinical research focuses on cancer care, spanning solid tumors and blood cancers. Studies in breast cancer, renal cell carcinoma, melanoma, lung cancer, colon cancer, and bladder cancer are exploring new ways to improve survival, reduce recurrence, and strengthen treatment effectiveness.

• Testing new immunotherapy and targeted therapy approaches for advanced and metastatic cancers
• Evaluating treatment options for lymphoma, leukemia, and myelodysplastic syndrome
• Studying adjuvant and maintenance strategies to prevent cancer recurrence

This research also includes trials aimed at improving outcomes for patients with hormone receptor-positive breast cancer and other hard-to-treat tumors, reflecting a strong oncology program with broad clinical expertise.

The department is also studying conditions in women’s health, especially endometriosis and endometrial cancer. These trials look at symptom relief, fertility-related concerns, and better treatment after surgery for gynecologic cancer.

• Assessing therapies for endometriosis-associated pain and infertility
• Evaluating treatments for high-risk endometrial cancer
• Improving post-surgical care and disease control in gynecologic oncology

The work at Tampere University Hospital combines cancer research with practical questions that matter to patients, such as comfort, recovery, and long-term disease management.

Research in these areas includes studies on heart failure, atrial fibrillation, and stroke prevention, alongside trials in chronic lymphocytic leukemia and other blood disorders. The overall goal is to improve treatment effectiveness while balancing safety in complex patient groups.

• Testing new options for stroke prevention in patients with kidney disease and atrial fibrillation
• Evaluating therapies for heart failure and related cardiac dysfunction
• Studying better treatment strategies for chronic lymphocytic leukemia

These trials reflect a broad interest in both cardiovascular risk reduction and hematology, with attention to patients who often have multiple medical conditions.

The site is investigating conditions such as ulcerative colitis, acute appendicitis, chronic obstructive pulmonary disease, and non-small cell lung cancer. This research aims to refine everyday treatment decisions and improve long-term disease control.

• Exploring better management of ulcerative colitis
• Studying whether antibiotics can be avoided in uncomplicated acute appendicitis
• Evaluating new approaches for COPD and lung-related disease burden

The clinical trial portfolio shows interest in both chronic inflammatory disease and respiratory illness, with a focus on practical treatment effectiveness and patient safety.

Research also includes prostate cancer and public health-related questions that affect treatment quality and daily well-being. One example is work examining supportive care during cancer therapy, while other studies focus on reducing complications from common diseases.

• Studying supportive care for patients with prostate cancer
• Looking at ways to improve treatment tolerance and quality of life
• Addressing broader health outcomes linked to routine clinical care

Across these areas, the research at Tampere University Hospital reflects a patient-centered approach that combines disease treatment with attention to everyday health impacts.